cefuroxime 750 mg powder for solution for injection/infusion
fresenius kabi deutschland gmbh - cefuroxime sodium - powder for solution for injection/infusion - 750 milligram(s) - second-generation cephalosporins; cefuroxime
cefuroxime for injection
viatris limited - cefuroxime sodium 1.578 g equivalent to 1.5 g cefuroxime; - powder for injection - 1.5 g - active: cefuroxime sodium 1.578 g equivalent to 1.5 g cefuroxime
cefuroxime for injection
viatris limited - cefuroxime sodium 263mg equivalent 250 mg cefuroxime - powder for injection - 250 mg - active: cefuroxime sodium 263mg equivalent 250 mg cefuroxime
cefuroxime for injection
viatris limited - cefuroxime sodium 789mg equivalent to 750 mg cefuroxime; - powder for injection - 750 mg - active: cefuroxime sodium 789mg equivalent to 750 mg cefuroxime
cefuroxime 1.5 g powder for injection/infusion
flynn pharma limited - cefuroxime sodium - powder for solution for injection/infusion - 1.5 gram(s) - second-generation cephalosporins; cefuroxime
cefuroxime 750 mg powder for injection/infusion
flynn pharma limited - cefuroxime sodium - powder for solution for injection/infusion - 750 milligram(s) - second-generation cephalosporins; cefuroxime
cefuroxime 250 mg powder for solution for injection
stravencon ltd - cefuroxime sodium - powder for solution for injection - 250 milligram(s) - second-generation cephalosporins; cefuroxime
cefuroxime 750 mg powder for solution for injection
stravencon ltd - cefuroxime sodium - powder for solution for injection - 750 milligram(s) - second-generation cephalosporins; cefuroxime
cefuroxime 1500 mg powder for solution for injection or infusion
stravencon ltd - cefuroxime sodium - powder for solution for injection/infusion - 1500 milligram(s) - second-generation cephalosporins; cefuroxime
pharmacor cefuroxime cefuroxime 250mg film coated tablet blister pack
pharmacor pty ltd - cefuroxime axetil, quantity: 300.715 mg - tablet, film coated - excipient ingredients: crospovidone; calcium carbonate; microcrystalline cellulose; calcium stearate; croscarmellose sodium; purified water; colloidal anhydrous silica; sodium lauryl sulfate; titanium dioxide; hypromellose; propylene glycol; brilliant blue fcf aluminium lake - cefuroxime is indicated for the treatment of the following mild to moderately severe infections in adults caused by sensitive bacteria: acute upper respiratory infections: otitis media, sinusitis, tonsillitis and pharyngitis. acute exacerbations of chronic bronchitis, or acute bronchitis. skin and skin structure infections for example, furunculosis, pyoderma and impetigo. acute uncomplicated gonococcal urethritis, and cervicitis due to non-penicillinase producing gonococci.